Cutting edge: Agonistic effect of indomethacin on a prostaglandin D2 receptor, CRTH2

Journal of Immunology

Volumn 168, Issue 3, 2002, Pages 981-985

  Hirai, Hiroyuki ^a   Tanaka, Kazuya ^a   Takano, Shoichi ^a   Ichimasa, Michiko ^a   Nakamura, Masataka ^a   Nagata, Kinya ^a  

^a Kawagoe shi   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACEMETACIN; ACETYLSALICYLIC ACID; DICLOFENAC; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROSTAGLANDIN D2; PROSTAGLANDIN RECEPTOR; PROSTAGLANDIN RECEPTOR STIMULATING AGENT; SULINDAC;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BASOPHIL; CALCIUM TRANSPORT; CHEMOTAXIS; DRUG EFFECT; EOSINOPHIL; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL; TH2 CELL;

EID: 0036467346     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.3.981     Document Type: Article

References (28)

1. Mediators of inflammation
2. Immunomodulation by eicosanoids and anti-inflammatory drugs
3. Prostanoids and their receptors
4. 2 generation after activation of rat and human mast cells with anti-IgE
5. Inducible cyclooxygenase may have anti-inflammatory properties
6. 2 is an early anti-inflammatory signal in experimental colitis
7. Molecular cloning and characterization of the human prostanoid DP receptor
8. 2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2
9. 2 in the inhibition of epidermal Langerhans cell migration during schistosomiasis infection
10. 2 as a mediator of allergic asthma
11. 2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor
12. Selective expression of a novel surface molecule by human Th2 cells in vivo
13. CRTH2, an orphan receptor of T-helper-2-cells, is expressed on basophils and eosinophils and responds to mast cell-derived factor(s)
14. CRTH2 is the most reliable marker for the detection of circulating human type 2 Th and type 2 T cytotoxic cells in health and disease
15. + T cells during the early stage of pregnancy
16. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing
17. Prostaglandin endoperoxide H synthase-1 and -2
18. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs
19. Indomethacin is a competitive inhibitor of the binding of the chemotactic peptide formyl-Met-Leu-Phe to human polymorphonuclear leukocytes
20. 5,8,11,14-Eicosatetraynoic acid (ETYA) inhibits binding of N-formyl-methionyl-leucylphenylalanine (FMLP) to its receptor on human granulocytes: A note of caution
21. Chemical and biological studies on indomethacin, sulindac and their analogs
22. Selectivity of nonsteroidal anti-inflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase
23. Malignant transformation and antineoplastic actions of nonsteroidal anti-inflammatory drugs (NSAIDs) on cyclooxygenase-null embryo fibroblasts
24. Peroxisome proliferator-activated receptors α and γ are activated by indomethacin and other non-steroidal anti-inflammatory drugs
25. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
26. The nuclear PPARγ and immunoregulation: PPARγ mediates inhibition of helper T cell responses
27. Early histological features of small intestinal injury induced by indomethacin
28. 2 in modulating histamine release from human basophils